Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Apotea AB ( (SE:APOTEA) ) has provided an update.
Apotea AB has scheduled the publication of its Q4 2025 year-end report for 4 February 2026 at 07:30 CET, followed by a webcast presentation at 09:30 CET led by CEO Pär Svärdson and CFO Johan Mårild. By inviting investors, analysts, media and other stakeholders to an English-language webcast and optional teleconference, the company is maintaining transparency around its full-year 2025 performance, underlining its ambition to engage an international investor base and reinforcing its positioning as a leading digital pharmacy player in the Nordic region.
More about Apotea AB
Apotea AB is Sweden’s leading online pharmacy by market share, offering a wide assortment of pharmaceutical and health-related products with a focus on low prices and fast delivery to its three million active customers. The company aims to become the largest pharmacy in Sweden and the Nordics, has been ranked customers’ favourite e-commerce store in the 2024 E-barometern survey for the seventh consecutive year, and has expanded into Norway through its subsidiary Apotera.
Average Trading Volume: 183,693
Technical Sentiment Signal: Buy
See more data about APOTEA stock on TipRanks’ Stock Analysis page.